Cardica (CRDC) -8.8% premarket after it suspends enrollment in a European clinical trial of its...

|By:, SA News Editor

Cardica (CRDC) -8.8% premarket after it suspends enrollment in a European clinical trial of its MicroCutter Xpress 30 surgical cutting device because in a subset of uses it didn’t perform satisfactory in thicker tissue.